Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies
Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with…
Ler MaisEmbolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC
Embolic strokes of undetermined source: a clinical consensus statement of…
Ler MaisObese patients with atrial fibrillation are more efficiently protected from thrombosis under warfarin or xabans compared to non-obese patients; a systematic review and Meta-analysis of six randomized controlled trials
Obese patients with atrial fibrillation are more efficiently protected from…
Ler MaisPlatelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes
Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic…
Ler MaisDOACs for Older adults with Atrial Fibrillation and Falls: Results from the prospective single-centre DOAFF study
DOACs for Older adults with Atrial Fibrillation and Falls: Results…
Ler MaisModern imaging of acute pulmonary embolism
Modern imaging of acute pulmonary embolism C.M.M. de Jong a); L.J.M….
Ler MaisD-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results
D-dimer and risk of venous thromboembolism recurrence: Comparison of two…
Ler MaisCharacterization of a canine freeze-dried platelet-derived hemostatic agent: A preclinical model for surgical and traumatic hemorrhage
Characterization of a canine freeze-dried platelet-derived hemostatic agent: A preclinical…
Ler MaisPlatelet FcγRIIA: An emerging regulator and biomarker in cardiovascular disease and cancer
Platelet FcγRIIA: An emerging regulator and biomarker in cardiovascular disease…
Ler Mais